Aspergillus: nosocomial or community acquired?

Gliotoxin: Biosynthesis and biological activities

DH Scharf

2024

Inhibition of pyrimidine biosynthesis and salvage

Assoc. Prof. Fabio Gsaller, PhD

2024

Overview of Inhaled Mycotoxins from Indoor Exposure & Human Illness

Dr. Irene Grant

2024

Updated definition of allergic bronchopulmonary aspergillosis (ABPA) and assessment of therapeutic response

Ritesh Agarwal MD, DM

2024

Induced immunological defects in virus-associated pulmonary aspergillosis (VAPA)

Joost Wauters, MD, PhD Simon Feys, MD and Laura Seldeslachts, MSc

2024

Eosinophils or IgE–which determines response to biologics in ABPA?

Koichiro Asano

2024

Optimal antifungal strategies to prevent mould infections deaths in solid organ transplant recipients

Maricela Valerio Minero, MD, PhD

2024

Optimal antifungal strategies to prevent mould infections deaths in ICU patients

Daniele Roberto Giacobbe, MD, PhD

2024

Panaccione 0900 Saturday session 11

Ergot alkaloids

2024

PoC tests for antigen and antibody – Are they really point of care?

Robina Aerts, MD

2024